Cocoa and Metabolic Health in Prediabetes
Dietary Cocoa for Inhibition of Metabolic Endotoxemia and Glucose Intolerance
Sponsor: The Hershey Company
A NA clinical study on Prediabetes, this trial is completed. The trial is conducted by The Hershey Company and has accumulated 14 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Oct 2023 — Jul 2024 [monthly]
Completed NA
-
Sep 2022 — Oct 2023 [monthly]
Completed NA
-
Oct 2021 — Sep 2022 [monthly]
Completed NA
▶ Show 9 earlier versions
-
Apr 2021 — Oct 2021 [monthly]
Completed NA
-
Jan 2021 — Apr 2021 [monthly]
Completed NA
-
Oct 2020 — Jan 2021 [monthly]
Completed NA
-
Apr 2020 — Oct 2020 [monthly]
Completed NA
-
Oct 2019 — Apr 2020 [monthly]
Completed NA
-
Nov 2018 — Oct 2019 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Jun 2018 — Nov 2018 [monthly]
Unknown Status NA
-
Aug 2017 — Jun 2018 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Jun 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- The Hershey Company
- Virginia Polytechnic Institute and State University
For direct contact, visit the study record on ClinicalTrials.gov .